Galectin Therapeutics (GALT) Intangibles (2010 - 2016)
Galectin Therapeutics (GALT) posted quarterly Intangibles of $78000.0 for Q4 2016, little changed year-over-year from $78000.0 in Q1 2016, and up 2500.0% quarter-over-quarter from $3000.0 in Q3 2016.
Powered by 
Analysis
Galectin Therapeutics (GALT) Intangibles (2010 - 2016) Analysis & Trends
Galectin Therapeutics' Intangibles history runs 7 years deep, the most recent figure standing at $78000.0 for Q4 2016.
- In Q4 2016, Intangibles changed 0.0% year-over-year to $78000.0; the TTM figure through Dec 2016 stood at $78000.0 (changed 0.0% YoY), while the FY2016 annual figure was $78000.0, changed 0.0% from the prior year.
- Intangibles for Q4 2016 stood at $78000.0, up from $3000.0 in the prior quarter.
- The five-year high for Intangibles was $78000.0 in Q4 2013, with the low at $3000.0 in Q3 2016.
- The 5-year median for Intangibles is $22500.0 (2013), against an average of $28350.0.
- The sharpest annual moves came in 2014 and 2015: Intangibles slumped 80.77% in 2014, then surged 420.0% in 2015.
- Galectin Therapeutics' Intangibles stood at $30000.0 in 2012, then jumped by 160.0% to $78000.0 in 2013, then plunged by 80.77% to $15000.0 in 2014, then soared by 420.0% to $78000.0 in 2015, then changed by 0.0% to $78000.0 in 2016.
- Business Quant data shows GALT's Intangibles at $78000.0 in Q4 2016, $3000.0 in Q3 2016, and $5000.0 in Q2 2016.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 412.80 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 1.31 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 266.00 Mn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 63.28 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 60.96 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 93.49 Mn |
| 10 | Galectin Therapeutics | 304.34 Mn | 304.34 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2016 | 78,000.00 |
| Sep 30, 2016 | 3,000.00 |
| Jun 30, 2016 | 5,000.00 |
| Mar 31, 2016 | 7,000.00 |
| Dec 31, 2015 | 78,000.00 |
| Sep 30, 2015 | 10,000.00 |
| Jun 30, 2015 | 12,000.00 |
| Mar 31, 2015 | 14,000.00 |
| Dec 31, 2014 | 78,000.00 |
| Sep 30, 2014 | 17,000.00 |
| Jun 30, 2014 | 19,000.00 |
| Mar 31, 2014 | 21,000.00 |
| Dec 31, 2013 | 78,000.00 |
| Sep 30, 2013 | 24,000.00 |
| Jun 30, 2013 | 26,000.00 |
| Mar 31, 2013 | 28,000.00 |
| Dec 31, 2012 | 78,000.00 |
| Sep 30, 2012 | 33,000.00 |
| Jun 30, 2012 | 34,000.00 |
| Mar 31, 2012 | 35,000.00 |